• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED STENT; STENT, ILIAC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Renal Failure (2041); Respiratory Failure (2484); Blood Loss (2597)
Event Type  Injury  
Manufacturer Narrative
On completion of the investigation a follow up report will be submitted.
 
Event Description
Article received: eleshra, a.E.(2020).Short-term outcomes of the t-branch off-the-shelf multibranched stent graft for reintervention after previous infrarenal aortic repair.Journal of vascular surgery, 1-9.Purpose: the purpose of this study was to evaluate the outcome of t-branch (cook medical) stent graft for the treatment of thoracoabdominal and pararenal aortic aneurysms in patients who had previous infrarenal aortic repair.Method: a retrospective two-center study was undertaken.All consecutive patients who underwent endovascular repair using t-branch stent graft after previous infrarenal aortic repair between january 2010 and august 2018 were included.Conclusion: the use of t-branch off-the-shelf stent graft for the treatment of aortic disease in patients who had previous infrarenal aortic repair appears to be feasible, with acceptable early outcomes in terms of morbidity and mortality.Per the article adverse events included: endoleak, blood loss, acute renal injury, new onset dialysis, ischemic events and respiratory failure.
 
Manufacturer Narrative
This complaint is based on information within an article and no specific device information has been provided.As there is insufficient details of an actual device malfunction or adverse event that occurred the complaint cannot be confirmed.Conclusion: considering the retrospective observational design of the study, excellent technical success results of 97% despite a high percentage (28%) of patients with urgent presentation and high patency rates of the bridging stents and their targeted vessels, one can infer that getinge¿s advanta v12 stents performed as expected.H3 other text: product not available.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTA V12 COVERED STENT
Type of Device
STENT, ILIAC
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer Contact
lori gosselin
40 continental blvd
merrimack, NH 
MDR Report Key11356614
MDR Text Key232791520
Report Number3011175548-2021-00198
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/08/2021
Initial Date FDA Received02/21/2021
Supplement Dates Manufacturer Received06/28/2022
Supplement Dates FDA Received06/30/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-